Form 4 - Statement of changes in beneficial ownership of securities
SEC Accession No. 0000905148-26-003353
Filing Date
2026-07-27
Accepted
2026-07-27 16:07:54
Documents
1
Period of Report
2026-07-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 3526
  Complete submission text file 0000905148-26-003353.txt   5258
Mailing Address OPUS GENETICS, INC. 8 DAVIS DRIVE DURHAM NC 27713
Business Address
SCHACHLE JOSEPH K (Reporting) CIK: 0001145914 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34079 | Film No.: 261205807

Mailing Address 8 DAVIS DRIVE SUITE 220 DURHAM NC 27713
Business Address 8 DAVIS DRIVE SUITE 220 DURHAM NC 27713 (984) 884-6030
Opus Genetics, Inc. (Issuer) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)